litlas
Log inCreate account

Kevin Winthrop

Active 2001–2025

228
Papers
43,656
Citations
100
h-index
218
i10-index

Citations

Citations per year for Kevin Winthrop2001: 1 citations2002: 3 citations2003: 12 citations2004: 15 citations2005: 11 citations2006: 19 citations2007: 32 citations2008: 66 citations2009: 92 citations2010: 87 citations2011: 109 citations2012: 177 citations2013: 224 citations2014: 287 citations2015: 322 citations2016: 301 citations2017: 374 citations2018: 353 citations2019: 1,321 citations2020: 1,659 citations2021: 1,742 citations2022: 1,430 citations2023: 1,072 citations2024: 1,826 citations2025: 852 citations2026: 19 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,008 citing papers, 19.4% of this breakdownUnited Kingdom: 1,221 citing papers, 7.9% of this breakdownGermany: 833 citing papers, 5.4% of this breakdownChina: 830 citing papers, 5.3% of this breakdownItaly: 828 citing papers, 5.3% of this breakdownFrance: 714 citing papers, 4.6% of this breakdownCanada: 624 citing papers, 4% of this breakdownNetherlands: 623 citing papers, 4% of this breakdownJapan: 607 citing papers, 3.9% of this breakdownSpain: 537 citing papers, 3.5% of this breakdownAustralia: 446 citing papers, 2.9% of this breakdownSwitzerland: 362 citing papers, 2.3% of this breakdown
0%19.4%Other 31.5%

Institutions

Fields

  • Medicine81.8%
  • Immunology and Microbiology7.4%
  • Biochemistry, Genetics and Molecular Biology7.1%
  • Neuroscience0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Health Professions0.5%
  • Other2.1%

Topics

  • Rheumatoid Arthritis Research and Therapies9.9%
  • Mycobacterium research and diagnosis6.4%
  • Tuberculosis Research and Epidemiology5.1%
  • Spondyloarthritis Studies and Treatments3.9%
  • Autoimmune and Inflammatory Disorders Research3.1%
  • Systemic Lupus Erythematosus Research2.8%
  • Other68.8%

Coauthors

All papers

Open in search
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    Authors: Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher J Edwards, Kimme L Hyrich, Janet Pope, Savia de Souza, Tanja Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin Winthrop, Alejandro Balsa, Joan M. Bathon, Maya H Buch, Gerd R Burmester, Frank Buttgereit, Myrna Cardiel, Katerina Chatzidionysiou, Cătălin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques‐Eric Gottenberg, Espen A. Haavardsholm, Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 cited by 1,788

  2. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases

    Authors: David E. Griffith, Timothy R. Aksamit, Barbara A. Brown‐Elliott, Antonino Catanzaro, Charles L. Daley, Fred M. Gordin, Steven M. Holland, Robert Horsburgh, Gwen A. Huitt, Michael F. Iademarco, Michael D. Iseman, Kenneth N. Olivier, Stephen J. Ruoss, C. Fordham von Reyn, Richard J. Wallace, Kevin Winthrop - American Journal of Respiratory and Critical Care Medicine 2007 cited by 6,107

  3. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

    Authors: Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, C. Andréjak, Erik C. Böttger, Jan Brożek, David E. Griffith, Lorenzo Guglielmetti, Gwen A. Huitt, Shandra L. Knight, Philip Leitman, Theodore K. Marras, Kenneth N. Olivier, Miguel Santín, Jason E. Stout, Enrico Tortoli, Jakko van Ingen, Dirk Wagner, Kevin Winthrop - Clinical Infectious Diseases 2020 cited by 888

  4. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

    Authors: Gerd R Burmester, Stanley Cohen, Kevin Winthrop, Peter Nash, Alan D. Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P. Lacerda, Hannah Palac, Tim Shaw, Philip J. Mease, Emma Guttman‐Yassky - RMD Open 2023 cited by 210

  5. The emerging safety profile of JAK inhibitors in rheumatic disease

    Authors: Kevin Winthrop - Nature Reviews Rheumatology 2017 cited by 586

  6. Neutralizing monoclonal antibodies for treatment of COVID-19

    Authors: Peter C. Taylor, Andrew C. Adams, Matthew M. Hufford, Inmaculada de la Torre, Kevin Winthrop, Robert Gottlieb - Nature reviews. Immunology 2021 cited by 794

  7. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

    Authors: Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf‐­Henning Boehncke, Bente Appel Esbensen, Iain B. McInnes, Dennis McGonagle, Kevin Winthrop, Andra Bălănescu, P Bálint, Gerd R Burmester, Juan D. Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, Annamaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiró, Daniele Mauro, Helena Marzo‐Ortega, Philip J. Mease, Peter Nash, Wendy Wagenaar, L. Savage, Georg Schett, Stephanie Shoop-Worrall, Yoshiya Tanaka, Filip Van den Bosch, Annette H M van der Helm–van Mil, Alen Zabotti, Désirée van der Heijde, Josef S Smolen - Annals of the Rheumatic Diseases 2024 cited by 331

  8. Adult Patients With Bronchiectasis

    Authors: Timothy R. Aksamit, Anne E. O’Donnell, Alan R. Barker, Kenneth N. Olivier, Kevin Winthrop, M. Leigh Anne Daniels, Margaret M. Johnson, Edward Eden, David E. Griffith, Michael R. Knowles, Mark L. Metersky, Matthias Salathé, Byron Thomashow, Gregory Tino, Gerard Turino, Betsy Carretta, Charles L. Daley - CHEST Journal 2016 cited by 430

  9. Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    Authors: Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S Smolen, Désirée van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet Pope, Tsutomu Takeuchi, Kimme L Hyrich, Kevin Winthrop, Daniel Aletaha, Tanja Stamm, Jan W. Schoones, Robert Landewé - Annals of the Rheumatic Diseases 2022 cited by 168

  10. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

    Authors: Wouter Hoefsloot, Jakko van Ingen, Claire Andréjak, Kristian Ängeby, R. Bauriaud, Pascale Bémer, Natalie Beylis, Martin J. Boeree, J. Cacho, Violet Chihota, Érica Chimara, Gavin Churchyard, R. Cías, Rosa Daza, Charles L. Daley, P.N.R. Dekhuijzen, Diego Domingo, Francis Drobniewski, Jaime Esteban, Maryse Fauville‐Dufaux, Dorte Bek Folkvardsen, N Gibbons, E Gómez-Mampaso, Rosa Gonzalez, Harald Hoffmann, Po‐Ren Hsueh, Alexander Indra, Tomasz Jagielski, Frances Jamieson, Mateja Janković Makek, Eefje Jong, Joseph Keane, Wo-Jung Koh, Berit Lange, Sylvia Cardoso Leão, Rita Macedo, Turid Mannsåker, Theodore K. Marras, Jeannette Maugein, Heather Milburn, Tamas Mlinkó, Nora Morcillo, Kozo Morimoto, Dimitrios Papaventsis, Elia Palenque, Mar Paez-Peña, Claudio Piersimoni, Monika Polanová, Nalin Rastogi, Elvira Richter, María Jesús Ruiz‐Serrano, Anabela G. Silva, M. Pedro da Silva, Hülya Şimşek, Dick van Soolingen, Nóra Szabó, Rachel Thomson, Teresa Tórtola, Enrico Tortoli, Sarah Elizabeth Totten, Greg Tyrrell, Tuula Vasankari, Miguel Villar, Renata Walkiewicz, Kevin Winthrop, Dirk Wagner - European Respiratory Journal 2013 cited by 858

  11. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme

    Authors: Stanley Cohen, Ronald van Vollenhoven, Kevin Winthrop, Cristiano A. F. Zerbini, Yoshiya Tanaka, Louis Bessette, Ying Zhang, Nasser Khan, Barbara A. Hendrickson, Jeffrey Enejosa, Gerd R Burmester - Annals of the Rheumatic Diseases 2020 cited by 233

  12. A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

    Authors: Kenneth Kalunian, Richard Furie, Eric F. Morand, Ian N Bruce, Susan Manzi, Yoshiya Tanaka, Kevin Winthrop, Ihor Hupka, Lijin Zhang, Shanti Werther, Gabriel Abreu, Micki Hultquist, Raj Tummala, Catharina Lindholm, Hussein Al‐Mossawi - Arthritis & Rheumatology 2022 cited by 152

  13. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study

    Authors: David E. Griffith, Gina Eagle, Rachel Thomson, Timothy R. Aksamit, Naoki Hasegawa, Kozo Morimoto, Doreen Addrizzo‐Harris, Anne E. O’Donnell, Theodore K. Marras, Patrick A. Flume, Michael R. Loebinger, Lucy Morgan, Luigi Ruffo Codecasa, Adam T. Hill, Stephen J. Ruoss, Jae‐Joon Yim, Felix C. Ringshausen, Stephen K. Field, Julie V. Philley, Richard J. Wallace, Jakko van Ingen, Chris Coulter, James Nezamis, Kevin Winthrop - American Journal of Respiratory and Critical Care Medicine 2018 cited by 343

  14. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

    Authors: Peter Nash, Andreas Kerschbaumer, Thomas Dörner, Maxime Dougados, Roy Fleischmann, Klaus Geißler, Iain B. McInnes, Janet Pope, Désirée van der Heijde, Michaela Stoffer, Tsutomu Takeuchi, Michael Trauner, Kevin Winthrop, Maarten de Wit, Daniel Aletaha, Xenofon Baraliakos, Wolf‐­Henning Boehncke, Paul Emery, John D. Isaacs, Joel M. Kremer, Eun Bong Lee, Walter P. Maksymowych, Marieke Voshaar, Lai‐Shan Tam, Yoshiya Tanaka, Filip Van den Bosch, René Westhovens, Ricardo Machado Xavier, Josef S Smolen - Annals of the Rheumatic Diseases 2020 cited by 288

  15. Oral surveillance and JAK inhibitor safety: the theory of relativity

    Authors: Kevin Winthrop, Stanley Cohen - Nature Reviews Rheumatology 2022 cited by 196

  16. Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database

    Authors: Peter C. Taylor, Tsutomu Takeuchi, Gerd R Burmester, Patrick Durez, Josef S Smolen, Walter Deberdt, Maher Issa, Jorge Ross Terrés, Natalia Bello, Kevin Winthrop - Annals of the Rheumatic Diseases 2021 cited by 160

  17. The role of IL-6 in host defence against infections: immunobiology and clinical implications

    Authors: Stefan Rose‐John, Kevin Winthrop, Leonard H. Calabrese - Nature Reviews Rheumatology 2017 cited by 424

  18. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008–2015

    Authors: Kevin Winthrop, Theodore K. Marras, Jennifer Adjemian, Haixin Zhang, Ping Wang, Quanwu Zhang - Annals of the American Thoracic Society 2019 cited by 333

  19. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    Authors: Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, Josef S Smolen, Désirée van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet Pope, Tsutomu Takeuchi, Kimme L Hyrich, Kevin Winthrop, Daniel Aletaha, Tanja Stamm, Jan W. Schoones, Robert Landewé - Annals of the Rheumatic Diseases 2022 cited by 139

  20. Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

    Authors: Stanley Cohen, Yoshiya Tanaka, Xavier Mariette, Jeffrey R. Curtis, Eun Bong Lee, Peter Nash, Kevin Winthrop, Christina Charles‐Schoeman, Lisy Wang, Connie Chen, Kenneth Kwok, Pinaki Biswas, Andrea Shapiro, Ann Madsen, J. Wollenhaupt - RMD Open 2020 cited by 181

  21. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

    Authors: Anne R. Bass, Eliza F. Chakravarty, Elie A. Akl, Clifton O. Bingham, Leonard H. Calabrese, Laura C. Cappelli, Sindhu R. Johnson, Lisa F. Imundo, Kevin Winthrop, Reuben J. Arasaratnam, Lindsey R. Baden, Roberta Berard, S. Louis Bridges, Jonathan T. L. Cheah, Jeffrey R. Curtis, Polly J. Ferguson, Ida Hakkarinen, Karen Onel, Grayson Schultz, Vidya Sivaraman, Benjamin J. Smith, Jeffrey A. Sparks, Tiphanie P. Vogel, Eleanor Anderson Williams, Cassandra Calabrese, Joanne S. Cunha, Joann Fontanarosa, Miriah Gillispie‐Taylor, Elena Gkrouzman, Priyanka Iyer, Kimberly S. Lakin, Alexandra Legge, Mindy S. Lo, Megan M. Lockwood, Rebecca E. Sadun, Namrata Singh, Nancy Sullivan, Herman Tam, Marat Turgunbaev, Amy S. Turner, James Reston - Arthritis & Rheumatology 2023 cited by 195

  22. Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program

    Authors: Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman‐Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernán Valdez, Min Zhang, Saleem A. Farooqui, William Romero, Andrew Thorpe, Ricardo Rojo, Susan Johnson - American Journal of Clinical Dermatology 2021 cited by 139

  23. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

    Authors: Maxime Dougados, Martin Soubrier, Anna Antunez, Péter Bálint, Alejandro Balsa, Maya H Buch, Gustavo Casado, J. Detert, Bassel Elzorkany, Paul Emery, N. Hajjaj‐Hassouni, Masayoshi Harigai, Shue‐Fen Luo, Réka Kurucz, Gabriel Maciel, Emilio Martín Mola, Carlomaurizio Montecucco, Iain B. McInnes, Helga Radner, Josef S Smolen, Yeong-Wook Song, Harald E. Vonkeman, Kevin Winthrop, Jonathan Kay - Annals of the Rheumatic Diseases 2013 cited by 858

  24. Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis

    Authors: Eli M. Miloslavsky, Ray Naden, J. W. J. Bijlsma, Paul Brogan, E. Sherwood Brown, Paul Brunetta, Frank Buttgereit, Hyon K. Choi, Jean-Francois Dicaire, Jeffrey M. Gelfand, Liam G. Heaney, Liz Lightstone, Na Lu, Dédée F. Murrell, Michelle Petri, James T. Rosenbaum, Kenneth S. Saag, Murray B. Urowitz, Kevin Winthrop, John H. Stone - Annals of the Rheumatic Diseases 2016 cited by 231